analytics_image
Allergy Diagnostics Market Size, Growth Projections And Insights 2025-2035\
Vantage Market Research
Vantage Market Research

Reports - Allergy Diagnostics Market

iconBiotechnology and Life Sciences

Allergy Diagnostics Market

Allergy Diagnostics Market Size, Growth Projections And Insights 2025-2035 by Product & Service (Consumables, Instruments, Immunoassay Analyzers, ELISA Analyzers, Luminometers, Services, Other Instruments) by Allergen (Inhaled Allergens, Food Allergens, Drug Allergens, Other Allergens) by Test Type (In Vivo Tests, Skin Prick Tests, Patch Tests, In Vivo Tests, Other In Vitro Tests) by End User (Diagnostic Laboratories, Hospital-based Laboratories, Academic Research Institutes, Other End Users) by Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa

ppt icon
pdf icon
xlsx icon
power bi icon
immediate delivery icon

Industry Leaders Trust Us For Actionable Intelligence

Revenue Insights

Market Size in 2024

USD 5.99 Billion

Market Size By 2035

USD 13.48 Billion

CAGR (2025 - 2035)

7.66%

Largest Region

North America

Fastest Region

Asia Pacific

Base Year

2024

Historic Data

2021 - 2023

Forecast Period

2025 - 2035

Segments Covered

By Product & Service, By Allergen, By Test Type, By End User, By Region

Report Coverage

The final deliverable will encompass both quantitative and qualitative data, providing a comprehensive analysis of the market. The scope is customizable.

Overview

Allergy Diagnostics Market

Market Overview:

The global Allergy Diagnostics Market is valued at USD 5.99 Billion in 2024 and is projected to reach a value of USD 13.48 Billion by 2035 at a CAGR (Compound Annual Growth Rate) of 7.66% between 2025 and 2035. The increasing environmental pollution globally and the increasing access to healthcare insurance are estimated to enhance the growth of the Allergy Diagnostics market. Moreover, the Allergy Diagnostics market is expected to witness the highest growth during the forecast period owing to the high incidence of allergic diseases and associated heavy economic burden, and increasing funds by the organizations in the Allergy Diagnostics. The hazardous changes in the lifestyle of the population like the preference for junk food in the diet and increasing pollution are the other major factors driving the growth of the global Allergy Diagnostics market in the coming years. Furthermore, food allergies are showing the fastest growth nowadays due to the ignorance among individuals towards a healthy diet which is expected to increase the demand for Allergy Diagnostics during the forecast period. The utilization of mHealth in allergy diagnosis is the major factor driving the growth of the market during the forecast period. Furthermore, the latest diagnostic strategies for allergies and the research and analysis on new treatment approaches are presumed to be the key opportunities in the Allergy Diagnostics market in the upcoming years. The development of advanced technology indicates the great opportunity for growth of the Allergy Diagnostics market by introducing various types of blood tests in order to reduce further health issues. The rapidly changing lifestyle and the consumption of junk food especially among youngsters are driving the growth of the global Allergy Diagnostics market in the coming years.

Allergy Diagnostics Market Size, 2024 To 2035 (USD Billion)

Market Segmentation:

The Allergy Diagnostics market is segmented on the basis of product and services, allergen, test type, and end-user. On the basis of product and services, the market is segmented as Consumables, Instruments, Immunoassay Analyzers, ELISA Analyzers, Luminometers, other Instruments, and Services. Based on Allergen, the market is segmented as, Inhaled Allergens, Food Allergens, Drug Allergens, and other Allergens. On the basis of test-type, the market is segmented as In Vivo Tests, Skin Prick Tests, Patch Tests, Other In Vivo Tests, and In Vitro Tests. By end-user, the market is segmented as Diagnostic Laboratories, Hospital-based Laboratories, Academic Research Institutes, and Other End Users.

Consumable’s segment is projected to hold the largest share of the Allergy Diagnostics market in 2024

The consumables sector in the product and services segment is accounted to hold the largest share of the Allergy Diagnostics market during the year 2024. The growth of the consumables segment is mainly attributed to the increasing cases of allergies and the requirement of rapid tests in order to diagnose allergic conditions. The demand of the consumable segment has increased during the forecast period due to the arrival of covid-19 and significantly witness growth in the product and services segment.

In Vivo, tests are projected to acquire the largest share of the Allergy Diagnostics market during the forecast period

The In Vivo test type segment in the test type sector is accounted to hold the largest share of the Allergy Diagnostics market during the forecast period. The growth of In Vivo tests is primarily attributed to the increasing adoption of various tests in the Vivo tests segment such as skin prick tests. Moreover, these tests are safe convenient, dependable, and cost-effective and it is expected to increase the demand for Vivo tests in the coming years.

North America is expected to acquire the largest share of the Allergy Diagnostics market in the year 2024

The largest share of North America is primarily attributed to favorable reimbursement scenarios for the allergy diagnosis, availability of support and initiative by the associations, and rising incidence of allergies. The good healthcare infrastructure and advanced diagnostic technology in the region are increasing the demand for the Allergy Diagnostics market in North America.

In Asia the Allergy Diagnostics market is projected to witness the highest growth by the year 2024 owing to the developing healthcare infrastructures, increase in disposable income, increasing prevalence of allergic diseases, and increasing aging population in the region. Moreover, the increasing population and growth in the economies in developing countries like India, Japan, and China are projected to drive the growth of the Allergy Diagnostics market in Asia.

Some of the latest trends that are observed in the global Allergy Diagnostics market are the rising number of partnerships and collaborations, a growing number of mergers and acquisitions, increasing research and development activities, and new product launches which are expected to enhance the market growth in the upcoming years.

Competitive Landscape:

The major key players present in the Allergy Diagnostics market are adopting various strategies such as collaborations, new product launches, acquisitions, and expansions to increase the market share. The prime key players in the Allergy Diagnostics market are Thermo Fisher Scientific Inc., (US), Siemens Healthineers (Germany), Danaher (US), Omega Diagnostics Group PLC (UK), bioMérieux SA (France), EUROIMMUN Medizinische Labordiagnostika AG (Germany), HollisterStier Allergy (US), NEOGEN Corporation (US), Eurofins Scientific (Luxembourg), Stallergenes Greer (UK), HOB Biotech Group Corp., Ltd. (China), HYCOR Biomedical (US), Romer Labs Division Holding (Austria), R-Biopharm AG (Germany), AESKU.GROUP GmbH (Germany), ACON Laboratories, Inc. (US), Lincoln Diagnostics, Inc. (US), Astra Biotech GmbH (Germany), Minaris Medical America, Inc. (the US), and Erba Group (UK).

Recent Developments

  • October 2024, researchers at the University of Bern, in collaboration with Bern University Hospital, created a test aimed at streamlining allergy diagnoses. This tests efficacy has been validated using clinical samples from children and adolescents with peanut allergies.
  • October 2024, ALK licensed a new range of ALK-branded allergy skin testing devices. The lineup features the AllerTest-1, AllerTest-8, and AllerTest-10 devices designed for allergy testing and diagnosis.
  • October 2024, ATANIS Biotech, a frontrunner in allergy diagnostics, secured funding to propel its innovative allergy test, FAST-PASE, forward.
  • June 2024, YorkTest, a prominent player in the health and wellness sector, introduced a new initiative aimed at making at-home food sensitivity and allergy testing more accessible to United States households. This move underscores YorkTests dedication to empowering individuals with essential knowledge for informed health choices.


Allergy Diagnostics Market is segmented as follows:

Market Segmentation

ParameterDetails
Segment Covered

By Product & Service

  • Consumables
  • Instruments
  • Immunoassay Analyzers
  • ELISA Analyzers
  • Luminometers
  • Services
  • Other Instruments

By Allergen

  • Inhaled Allergens
  • Food Allergens
  • Drug Allergens
  • Other Allergens

By Test Type

  • In Vivo Tests
  • Skin Prick Tests
  • Patch Tests
  • In Vivo Tests
  • Other In Vitro Tests

By End User

  • Diagnostic Laboratories
  • Hospital-based Laboratories
  • Academic Research Institutes
  • Other End Users

By Region

  • North America (U.S., Canada, Mexico)
  • Europe (Germany, France, U.K., Italy, Spain, Nordic Countries, Benelux Union, Rest of Europe)
  • Asia-Pacific
  • Latin America (Brazil, Argentina, Rest of Latin America)
  • Middle East & Africa
Companies Covered
  • Thermo Fisher Scientific Inc.
  • (US)
  • Siemens Healthineers (Germany)
  • Danaher (US)
  • Omega Diagnostics Group PLC (UK)
  • bioMérieux SA (France)
  • Romer Labs Division Holding (Austria)
  • EUROIMMUN Medizinische Labordiagnostika AG (Germany)
  • HollisterStier Allergy (US)
  • NEOGEN Corporation (US)
  • Eurofins Scientific (Luxembourg)
  • Minaris Medical America
  • Inc. (US)
  • Stallergenes Greer (UK)
  • HOB Biotech Group Corp.
  • Ltd. (China)
  • HYCOR Biomedical (US)
  • R-Biopharm AG (Germany)
  • AESKU.GROUP GmbH (Germany)
  • ACON Laboratories
  • Inc. (US)
  • Lincoln Diagnostics
  • Inc. (US)
  • Astra Biotech GmbH (Germany)
  • and Erba Group (UK).
Customization ScopeEnjoy complimentary report customization—equivalent to up to 8 analyst working days—with your purchase. Customizations may include additions or modifications to country, regional, or segment-level data.
Pricing and purchase optionsAccess flexible purchase options tailored to your specific research requirements. Explore purchase options


Allergy Diagnostics Market is tabulated as follows:

Report coverage & Deliverables

Our PDF Reports And Online Dashboard
Will Help You Stay Ahead In The Market.

    Key features include:

  • Check
    Competitive benchmarking
  • Check
    Historical data and future forecasts
  • Check
    Company-wise revenue breakdown
  • Check
    Regional growth opportunities
  • Check
    Latest market trends and dynamics
  • Check
    Impact of emerging technologies like AI and automation
  • Check
    Key regulatory updates and ESG considerations

FAQ‘s

Related Reports

vantage logo

Vantage Market Research & Consultancy Services is all about providing accurate and reliable market intelligence to its clients for the seamless execution of their business growth strategies.

© 2025 Vantage Market Research. All right reserved
Secured Bysecured by